Although the exact mechanism of upregulation of KLK6 and other proteases in the presence of APC mutations is not completely understood, our study contributes to the recognition of KLK6’s role in tumor development and demonstrates a possibility for using KLK6 for CRC detection and therapy. This evidence concerns the gene KLK6 and colorectal carcinoma.